Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

GENT: Disclosure of large shareholding

Gentian Diagnostics
Oslo, 22 May 2025, Notification of trade

Carpe Diem Afseth AS ("Carpe Diem") has today, 22 May 2025, acquired 10,000
shares in Gentian Diagnostics ASA ("Gentian"). Following the acquisition, Carpe
Diem owns 772,816 shares in Gentian which represents a total of 5.01% of
Gentian's issued shares and
voting rights (based on 15,422,350 shares issued by Gentian). Carpe Diem is 100%
owned by John Afseth who has no formal role in Gentian.

This disclosure is made pursuant to section 4-2 of the Norwegian Securities
Trading Act and is subject to the disclosure requirement pursuant to section
5-12 of the Norwegian Securities Trading Act.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.